Clinical value of 18-fluorine-fluorodihydroxyphenylalanine positron emission tomography/computed tomography in the follow-up of medullary thyroid carcinoma. - Wikidata - awgldk - TriplyDB

Clinical value of 18-fluorine-fluorodihydroxyphenylalanine positron emission tomography/computed tomography in the follow-up of medullary thyroid carcinoma.

Clinical value of 18-fluorine-fluorodihydroxyphenylalanine positron emission tomography/computed tomography in the follow-up of medullary thyroid carcinoma.

http://www.wikidata.org/entity/Q42471133

about

RET mutations in a large indian family with medullary thyroid carcinoma.Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.18F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography for Other Thyroid Cancers: Medullary, Anaplastic, Lymphoma and So Forth Detection rate of recurrent medullary thyroid carcinoma using fluorine-18 fluorodeoxyglucose positron emission tomography: a meta-analysis.18F-fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their type Depicting medullary thyroid cancer recurrence: the past and the future of nuclear medicine imaging.Exploring the role of technitium-99m dimercaptosuccinyl acid (V) scan in medullary carcinoma thyroid patients with postoperative persistent hypercalcitoninemia in the era of positron emission tomography-computerized tomography Role of positron emission tomography imaging in Multiple Endocrine Neoplasia syndromes.(18)F-DOPA PET/CT in the diagnosis and localization of persistent medullary thyroid carcinoma.PET Imaging in Recurrent Medullary Thyroid Carcinoma.Thyroglobulin levels and thyroglobulin doubling time independently predict a positive 18F-FDG PET/CT scan in patients with biochemical recurrence of differentiated thyroid carcinoma.Predictive and prognostic value of 18F-DOPA PET/CT in patients affected by recurrent medullary carcinoma of the thyroid.Diagnostic utility of PET/CT with 18F-DOPA and 18F-FDG in persistent or recurrent medullary thyroid carcinoma: the importance of calcitonin and carcinoembryonic antigen cutoff.Optimal threshold of stimulated serum thyroglobulin level for 18F-FDG PET/CT imaging in patients with thyroid cancer.¹⁸F-FDG PET predicts survival after pretargeted radioimmunotherapy in patients with progressive metastatic medullary thyroid carcinoma.Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma Evolving paradigms for successful molecular imaging of medullary thyroid carcinoma Diagnostic accuracy of [18F]DOPA PET and PET/CT in patients with neuroendocrine tumors: a meta-analysis

P2860

Q34069272-EA8F2AD8-B5B3-4B9A-9346-ADC10335A961 Q34468665-8203C390-02CF-47DB-B79C-81EF90A1FBF9 Q37700110-6DFF5EE1-BED3-4D3D-AA57-03599419C931 Q38004952-2CDB2A69-50B3-44D6-80F5-94EEA5D3FEF5 Q38082417-08B100DA-3D9A-4EC8-9852-578E66E43622 Q38203509-F2738F16-D079-4067-BFB1-DC66A6364B7B Q38248262-5A695AE4-B514-435A-8B23-E67DF4F5709D Q38966288-585CF22C-9F56-45FE-990C-22A23D1F6E7B Q40397059-D8EC53D7-2CD4-466F-BCD2-0C8A6601C1E2 Q42254140-D99F08AA-4DE4-4AE7-B50B-666889C4F0C7 Q46983835-03744D44-CD8C-4905-8F94-1C7C2729E910 Q47846912-D1B60E19-E741-4E19-9103-4B2AB8151B9B Q48227522-E9228EC8-3032-4FCA-B158-438EEBC23DAF Q52940648-F90DCFEB-1277-4B65-823D-D7B74D076653 Q53066863-63AF4645-A8D0-49B3-8C1B-0F2EE55EC67F Q57998575-67D4C69B-0721-4A02-873B-D17E93B63098 Q57998577-077C22AC-2C8C-4D88-8708-C6735F6AD1DF Q58005428-31C2699A-1120-42B1-BE56-4267EE026708

P2860

Clinical value of 18-fluorine-fluorodihydroxyphenylalanine positron emission tomography/computed tomography in the follow-up of medullary thyroid carcinoma.

http://www.wikidata.org/entity/Q42471133

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Clinical value of 18-fluorine- ...... f medullary thyroid carcinoma.

@en

Clinical value of 18-fluorine- ...... f medullary thyroid carcinoma.

@nl

type

label

Clinical value of 18-fluorine- ...... f medullary thyroid carcinoma.

@en

Clinical value of 18-fluorine- ...... f medullary thyroid carcinoma.

@nl

prefLabel

Clinical value of 18-fluorine- ...... f medullary thyroid carcinoma.

@en

Clinical value of 18-fluorine- ...... f medullary thyroid carcinoma.

@nl

P1433

Q42471133-1316A947-9CAA-40EA-82D1-220D91F21205

P1476

Q42471133-5FB55A03-2C6D-4D34-99E7-94BE62352429

P2093

Q42471133-0519705B-56A9-460C-883D-ED5F79FA2270

Q42471133-0A3179B9-24B2-4389-B75E-E2853DA573FB

Q42471133-0C7A9060-5FD0-405D-89EE-2098C96DEE7A

Q42471133-731043B1-EA17-420F-B36B-3C3CCD0058A7

Q42471133-9A658E24-D986-4F83-B79D-F3FF93852D45

Q42471133-A20B0158-2FF2-4596-8C78-680458AFBBA3

Q42471133-A71CEB9D-1AD2-4907-90DC-48ED1A456205

Q42471133-B96A6B89-F462-4088-A363-926925423932

Q42471133-C5D228A6-228D-4392-9C0F-18690A42F2C4

P304

Q42471133-6B9613B6-D760-400E-9CE9-F335C276F8E2

P31

Q42471133-3A347F93-933A-49EC-AAB5-37CF8EB00C45

P356

Q42471133-B7B71A04-A6C5-4141-B183-4BC72B21474E

P433

Q42471133-3D047D32-828E-4ED2-8C94-CEE2CC04E9CD

P478

Q42471133-24E3F0F9-0552-4234-9912-34F341B25D51

P50

Q42471133-BC0FE07E-C656-4D6E-871C-F5A8123F7E78

Q42471133-D0F46461-5871-40DC-813E-5DFF22E6258E

Q42471133-E1137385-2C6F-4706-9360-D38CDEB3F5DE

P577

Q42471133-FF9A4B92-538E-4A84-96D1-904F81241C2B

P698

Q42471133-DC4D9D52-669B-435F-8A8A-753BE476525B

P356

P1433

P1476

Clinical value of 18-fluorine- ...... f medullary thyroid carcinoma.

@en

P2093

Christoph Solbach

http://www.w3.org/2001/XMLSchema#string

Felix M Mottaghy

http://www.w3.org/2001/XMLSchema#string

Frederik A Verburg

http://www.w3.org/2001/XMLSchema#string

Gerhard Glatting

http://www.w3.org/2001/XMLSchema#string

Katrin Zeich

http://www.w3.org/2001/XMLSchema#string

Markus Luster

http://www.w3.org/2001/XMLSchema#string

Sandra Pauls

http://www.w3.org/2001/XMLSchema#string

Sven N Reske

http://www.w3.org/2001/XMLSchema#string

Wolfram Karges

http://www.w3.org/2001/XMLSchema#string

P304

527-533

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/THY.2009.0342

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

Andreas K. Buck

P577

2010-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20450432

http://www.w3.org/2001/XMLSchema#string